Elicio Therapeutics (ELTX) Return on Sales [ROS] (2020 - 2024)
Elicio Therapeutics (ELTX) reported Return on Sales [ROS] of -3946.09% for Q1 2023, down 3067.15 percentage points from -878.94% a year earlier and down 2535.93 percentage points from the prior quarter.
Powered by 
Analysis
Elicio Therapeutics (ELTX) Return on Sales [ROS] (2020 - 2024) Analysis & Trends
For FY2022, Elicio Therapeutics posted Return on Sales [ROS] of -1031.42%, down 892.59 percentage points from FY2021.
- By year, Return on Sales [ROS] came in at -138.84% in FY2021 (+1780.37 pp) and -1919.20% in FY2020.
- The Q1 2023 figure ranks as the lowest quarterly Return on Sales [ROS] since Q1 2021.
- Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +726.12 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2022 (a gain of 4495.45 percentage points); the low point was Q1 2021 (a drop of 3921.33 percentage points).
- Per Business Quant data, the three quarters before Q1 2023 came in at -1410.17% (Q4 2022), -41.97% (Q3 2022) and -954.36% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 28.37% |
| 10 | Elicio Therapeutics | 35.41 Mn | -42.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -6,827.33% |
| Dec 31, 2023 | -12,522.67% |
| Sep 30, 2023 | -4,378.46% |
| Jun 30, 2023 | -19,941.03% |
| Mar 31, 2023 | -3,946.09% |
| Dec 31, 2022 | -1,410.17% |
| Sep 30, 2022 | -41.97% |
| Jun 30, 2022 | -954.36% |
| Mar 31, 2022 | -878.94% |
| Dec 31, 2021 | 56.41% |
| Sep 30, 2021 | -1,079.32% |
| Jun 30, 2021 | -3,378.52% |
| Mar 31, 2021 | -5,374.39% |
| Dec 31, 2020 | -3,017.43% |
| Sep 30, 2020 | -1,400.85% |
| Jun 30, 2020 | -2,368.86% |
| Mar 31, 2020 | -1,453.06% |
API Access
Elicio Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ELTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();